Literature DB >> 27572543

Soluble and pelletable factors in porcine, canine and human notochordal cell-conditioned medium: implications for IVD regeneration.

F C Bach1, S A de Vries, F M Riemers, J Boere, F W van Heel, M van Doeselaar, S S Goerdaya, P G Nikkels, K Benz, L B Creemers, A F Maarten Altelaar, B P Meij, K Ito, M A Tryfonidou.   

Abstract

During intervertebral disc (IVD) maturation, notochordal cells (NCs) are replaced by chondrocyte-like cells (CLCs) in the nucleus pulposus, suggesting that NCs play a role in maintaining tissue health. Affirmatively, NC-conditioned medium (NCCM) exerts regenerative effects on CLC proliferation and extracellular matrix (ECM) production. The aim of this study was to identify NC-secreted substances that stimulate IVD regeneration. By mass spectrometry of porcine, canine and human NCCM, 149, 170 and 217 proteins were identified, respectively, with 66 proteins in common. Mainly ECM-related proteins were identified, but also organelle-derived and membrane-bound vesicle proteins. To determine whether the effect of NCCM was mediated by soluble and/or pelletable factors, porcine and canine NCCM were separated into a soluble (NCCM-S; peptides and proteins) and pelletable (NCCM-P; protein aggregates and extracellular vesicles) fraction by ultracentrifugation, and tested on bovine and canine CLCs in vitro, respectively. In each model, NCCM-S exerted a more pronounced anabolic effect than NCCM-P. However, glycosaminoglycan (GAG) uptake from the medium into the carrier gel prevented more definite conclusions. While the effect of porcine NCCM-P on bovine CLCs was negligible, canine NCCM-P appeared to enhance GAG and collagen type II deposition by canine CLCs. In conclusion, porcine and canine NCCM exerted their anabolic effects mainly through soluble factors, but also the pelletable NCCM factors showed moderate regenerative potential. Although the regenerative potential of NCCM-P should not be overlooked, future studies should focus on unraveling the protein-based regenerative mechanism from NCCM produced from isolated NCs, e.g. by NCCM fractionation and pathway blocking studies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27572543     DOI: 10.22203/ecm.v032a11

Source DB:  PubMed          Journal:  Eur Cell Mater        ISSN: 1473-2262            Impact factor:   3.942


  14 in total

Review 1.  Defects in intervertebral disc and spine during development, degeneration, and pain: New research directions for disc regeneration and therapy.

Authors:  Sarthak Mohanty; Chitra L Dahia
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-04-11       Impact factor: 5.814

Review 2.  Mechanisms and clinical implications of intervertebral disc calcification.

Authors:  Uruj Zehra; Marianna Tryfonidou; James C Iatridis; Svenja Illien-Jünger; Fackson Mwale; Dino Samartzis
Journal:  Nat Rev Rheumatol       Date:  2022-05-09       Impact factor: 32.286

Review 3.  Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations.

Authors:  Tyler J DiStefano; Keti Vaso; George Danias; Henry N Chionuma; Jennifer R Weiser; James C Iatridis
Journal:  Adv Healthc Mater       Date:  2021-07-23       Impact factor: 9.933

4.  Notochordal-cell derived extracellular vesicles exert regenerative effects on canine and human nucleus pulposus cells.

Authors:  Frances Bach; Sten Libregts; Laura Creemers; Björn Meij; Keita Ito; Marca Wauben; Marianna Tryfonidou
Journal:  Oncotarget       Date:  2017-10-04

5.  NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease.

Authors:  Ajay Matta; Muhammad Zia Karim; Hoda Gerami; Peter Jun; Martha Funabashi; Greg Kawchuk; Alyssa Goldstein; Warren Foltz; Marshall Sussman; Bjorn C Eek; W Mark Erwin
Journal:  Sci Rep       Date:  2018-11-14       Impact factor: 4.379

6.  Induction of notochordal differentiation of bone marrow mesenchymal‑derived stem cells via the stimulation of notochordal cell‑rich nucleus pulposus tissue.

Authors:  Defang Li; Qingmin Zeng; Zengxin Jiang; Lei Ding; Wei Lu; Mengxuan Bian; Jingping Wu
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

Review 7.  Notochordal Cell-Based Treatment Strategies and Their Potential in Intervertebral Disc Regeneration.

Authors:  Frances C Bach; Deepani W Poramba-Liyanage; Frank M Riemers; Jerome Guicheux; Anne Camus; James C Iatridis; Danny Chan; Keita Ito; Christine L Le Maitre; Marianna A Tryfonidou
Journal:  Front Cell Dev Biol       Date:  2022-03-14

8.  Notochordal cell matrix as a bioactive lubricant for the osteoarthritic joint.

Authors:  S A H de Vries; M van Doeselaar; H J Kaper; P K Sharma; K Ito
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

9.  Biologic canine and human intervertebral disc repair by notochordal cell-derived matrix: from bench towards bedside.

Authors:  Frances C Bach; Anna R Tellegen; Martijn Beukers; Alberto Miranda-Bedate; Michelle Teunissen; Willem A M de Jong; Stefan A H de Vries; Laura B Creemers; Karin Benz; Björn P Meij; Keita Ito; Marianna A Tryfonidou
Journal:  Oncotarget       Date:  2018-05-29

10.  Part 1: profiling extra cellular matrix core proteome of human fetal nucleus pulposus in search for regenerative targets.

Authors:  Shanmuganathan Rajasekaran; Chitraa Tangavel; Niek Djuric; Muthurajan Raveendran; Dilip Chand Raja Soundararajan; Sharon Miracle Nayagam; Monica Steffi Matchado; K S Sri Vijay Anand
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.